Skip to menu Skip to content Skip to footer

2012

Journal Article

Multimodality vascular imaging in CKD: Divergence of risk between measured parameters

Petchey, William G., Hawley, Carmel M., Johnson, David W., Haluska, Brian A., Watkins, Trevor W. and Isbel, Nicole M. (2012). Multimodality vascular imaging in CKD: Divergence of risk between measured parameters. Nephrology, Dialysis, Transplantation, 27 (3), 1004-1012. doi: 10.1093/ndt/gfr397

Multimodality vascular imaging in CKD: Divergence of risk between measured parameters

2012

Journal Article

High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease

Mutsando, Howard, Fahim, Magid, Gill, Devinder S., Hawley, Carmel M., Johnson, David W., Maher, K. Gandhi, Marlton, Paula V., Mar Fan, Helen G. and Mollee, Peter N. (2012). High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease. American Journal of Blood Research, 2 (1), 66-70.

High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease

2012

Book Chapter

How do Clinical Outcomes of Automated Peritoneal Dialysis Compare with those of Continuous Ambulatory Peritoneal Dialysis?

Badve, Sunil V., Hawley, Carmel M. and Johnson, David W. (2012). How do Clinical Outcomes of Automated Peritoneal Dialysis Compare with those of Continuous Ambulatory Peritoneal Dialysis?. Issues in Dialysis. (pp. xx-xx) edited by Stephen Z. Fadem. New York, NY, U.S.A.: Nova Science Publishers.

How do Clinical Outcomes of Automated Peritoneal Dialysis Compare with those of Continuous Ambulatory Peritoneal Dialysis?

2012

Conference Publication

Dapsone as second-line pneumocystis jirovecii pneumonia prophylaxis: experience from the Queensland renal transplant service

Osama, Al-Bermani, Bhadran, Bose, Sheryn, Wang, Christopher, Xu, Anthony, Griffin, Carmel, Hawley, Scott, Campbell and Nikky, Isbel (2012). Dapsone as second-line pneumocystis jirovecii pneumonia prophylaxis: experience from the Queensland renal transplant service. 30th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, ACT, Australia, 27-29 June 2012. London, United Kingdom: Nature. doi: 10.1038/icb.2012.35

Dapsone as second-line pneumocystis jirovecii pneumonia prophylaxis: experience from the Queensland renal transplant service

2012

Conference Publication

Two cases of atypical haemolytic uremic syndrome treated with Eculizumab

Bose, B., Mallett, A., Badve, S. V., Johnson, D. W., Hawley, C., Mudge, D., Van Eps, C., Campbell, S. and Isbel, N. (2012). Two cases of atypical haemolytic uremic syndrome treated with Eculizumab. 48th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Auckland, New Zealand, 27‐29 August 2012. Hoboken, NJ United States: Wiley-Blackwell.

Two cases of atypical haemolytic uremic syndrome treated with Eculizumab

2012

Journal Article

Daily Variation in Death in Patients Treated by Long-term Dialysis: Comparison of In-Center Hemodialysis to Peritoneal and Home Hemodialysis

Krishnasamy, R., Badve, S.V., Hawley, C.M., McDonald, S.P., Boudville, N., Brown, F.G., Polkinghorne, K.R., Bannister, K.M., Wiggins, K.J., Clayton, P. and Johnson, D.W. (2012). Daily Variation in Death in Patients Treated by Long-term Dialysis: Comparison of In-Center Hemodialysis to Peritoneal and Home Hemodialysis. American Journal of Kidney Diseases, 61 (1), 96-103. doi: 10.1053/j.ajkd.2012.07.008

Daily Variation in Death in Patients Treated by Long-term Dialysis: Comparison of In-Center Hemodialysis to Peritoneal and Home Hemodialysis

2012

Journal Article

Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis

Van Eps, Carolyn, Hawley, Carmel, Jeffries, Janine, Johnson, David W., Campbell, Scott, Isbel, Nicole, Mudge, David W. and Prins, Johannes (2012). Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology, 17 (1), 42-47. doi: 10.1111/j.1440-1797.2011.01520.x

Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis

2012

Journal Article

Repeated Peritoneal Dialysis-Associated Peritonitis: A Multicenter Registry Study

Thirugnanasambathan, Thulasi, Hawley, Carmel M., Badve, Sunil V., McDonald, Stephen P., Brown, Fiona G., Boudville, Neil, Wiggins, Kathryn J., Bannister, Kym M., Clayton, Philip and Johnson, David W. (2012). Repeated Peritoneal Dialysis-Associated Peritonitis: A Multicenter Registry Study. American Journal of Kidney Diseases, 59 (1), 84-91. doi: 10.1053/j.ajkd.2011.06.018

Repeated Peritoneal Dialysis-Associated Peritonitis: A Multicenter Registry Study

2012

Journal Article

The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial

McMahon, Emma J., Bauer, Judith D., Hawley, Carmel M., Isbel, Nicole M., Stowasser, Michael, Johnson, David W., Hale, Rachael E. and Campbell, Katrina L. (2012). The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial. BMC Nephrology, 13 (1) 137. doi: 10.1186/1471-2369-13-137

The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial

2012

Journal Article

Biocompatible peritoneal dialysis fluids: Clinical outcomes

Cho, Yeoungjee, Badve, Sunil V., Hawley, Carmel M., Wiggins, Kathryn and Johnson, David W. (2012). Biocompatible peritoneal dialysis fluids: Clinical outcomes. International Journal of Nephrology, 2012 (Article number: 812609) 812609, 1-9. doi: 10.1155/2012/812609

Biocompatible peritoneal dialysis fluids: Clinical outcomes

2012

Journal Article

Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function

Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Boudville, Neil C., Wiggins, Kathryn J., Bannister, Kym M. and Johnson, David W. (2012). Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function. Nephrology, Dialysis, Transplantation, 27 (1), 381-387. doi: 10.1093/ndt/gfr274

Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function

2012

Conference Publication

NXSTAGE Queensland health pilot program the early Australian NXSTAGE experience: is NXSTAGE really the next stage in home haemodialysis?

Lee, A., Killen, J-P., Hawley, C., Jeffries, J., Equinox, K., Johnson, D., Campbell, S., Isbel, N., Mudge, D., Badve, S. and Van Eps, C. (2012). NXSTAGE Queensland health pilot program the early Australian NXSTAGE experience: is NXSTAGE really the next stage in home haemodialysis?. 48th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Auckland, New Zealand, 27‐29 August 2012. Hoboken, NJ United States: Wiley-Blackwell Publishing.

NXSTAGE Queensland health pilot program the early Australian NXSTAGE experience: is NXSTAGE really the next stage in home haemodialysis?

2012

Conference Publication

Serum fetuin-A and bone mineral markers among patients with chronic kidney disease stage 3 and 4

Krishnasamy, R., Elder, G., Hawley, C. and Isbel, N. (2012). Serum fetuin-A and bone mineral markers among patients with chronic kidney disease stage 3 and 4. 48th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Auckland, New Zealand, 27-29 August 2012. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/j.1440-1797.2012.01633.x

Serum fetuin-A and bone mineral markers among patients with chronic kidney disease stage 3 and 4

2012

Journal Article

The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study

Cho, Yeoungjee, Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Boudville, Neil, Wiggins, Kathryn J., Bannister, Kym M., Clayton, Philip and Johnson, David W. (2012). The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrology, 13 (1) 41, 41.1-41.17. doi: 10.1186/1471-2369-13-41

The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study

2011

Journal Article

Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients

Barraclough, Katherine A, Isbel, Nicole M., McWhinney, Brett C., Ungerer, Jacobus P. J., Medley, Gregory, Johnson, David W., Hawley, Carmel M., Leary, Diana R., Campbell, Scott B. and Staatz, Christine E. (2011). Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients. European Journal of Clinical Pharmacology, 67 (12), 1243-1252. doi: 10.1007/s00228-011-1071-y

Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients

2011

Journal Article

Home Hemodialysis in Australia and New Zealand: How and Why it has been Successful

Agar, John W. M., Hawley, Carmel M. and Kerr, Peter G. (2011). Home Hemodialysis in Australia and New Zealand: How and Why it has been Successful. Seminars in Dialysis, 24 (6), 658-663. doi: 10.1111/j.1525-139X.2011.00992.x

Home Hemodialysis in Australia and New Zealand: How and Why it has been Successful

2011

Journal Article

Alternate Night Nocturnal Hemodialysis: The Australian Experience

Kerr, Peter G., Agar, John W. M. and Hawley, Carmel M. (2011). Alternate Night Nocturnal Hemodialysis: The Australian Experience. Seminars in Dialysis, 24 (6), 664-667. doi: 10.1111/j.1525-139X.2011.00997.x

Alternate Night Nocturnal Hemodialysis: The Australian Experience

2011

Journal Article

Effect of dialysis modality on survival of hepatitis C-infected ESRF patients

Bose, Bhadran, McDonald, Stephen P., Hawley, Carmel M., Brown, Fiona G., Badve, Sunil V., Wiggins, Kathryn J., Bannister, Kym M., Boudville, Neil, Clayton, Philip and Johnson, David W. (2011). Effect of dialysis modality on survival of hepatitis C-infected ESRF patients. Clinical Journal of the American Society of Nephrology, 6 (11), 2657-2661. doi: 10.2215/CJN.02200311

Effect of dialysis modality on survival of hepatitis C-infected ESRF patients

2011

Journal Article

Home Hemodialysis and Mortality Risk in Australian and New Zealand Populations

Marshall, Mark R., Hawley, Carmel M., Kerr, Peter G., Polkinghorne, Kevan R., Marshall, Roger J., Agar, John W.M. and McDonald, Stephen P. (2011). Home Hemodialysis and Mortality Risk in Australian and New Zealand Populations. American Journal of Kidney Diseases, 58 (5), 782-793. doi: 10.1053/j.ajkd.2011.04.027

Home Hemodialysis and Mortality Risk in Australian and New Zealand Populations

2011

Journal Article

End-stage kidney disease due to scleroderma-outcomes in 127 consecutive ANZDATA registry cases

Siva, Brian, McDonald, Stephen P., Hawley, Carmel M., Rosman, Johan B., Brown, Fiona G., Wiggins, Kathryn J., Bannister, Kym M., Campbell, Scott B. and Johnson, David W. (2011). End-stage kidney disease due to scleroderma-outcomes in 127 consecutive ANZDATA registry cases. Nephrology Dialysis Transplantation, 26 (10), 3165-3171. doi: 10.1093/ndt/gfq861

End-stage kidney disease due to scleroderma-outcomes in 127 consecutive ANZDATA registry cases